Search

everythinglearnresearchcommunity

for

Search:↓

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

p2y5, now called LPA6, is a receptor important for human hair growth.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Gintonin-enriched fraction promotes hair growth and could be a potential alopecia treatment.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

The enzyme PA-PLA1α is important for proper hair follicle development.

Targeting LPA could help treat skin disorders.

Lysophosphatidic acid boosts stem cell growth and movement by creating reactive oxygen species.

LPA 4 helps control blood and lymph vessel development in zebrafish.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Upadacitinib may effectively treat resistant lichen planopilaris.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.